Powerful cholesterol drug cuts heart attack risk by 31% - sciencedaily.com

Powerful cholesterol drug cuts heart attack risk by 31%  sciencedaily.comPCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV  TCTMD.comPCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes  MedscapeEvolocumab Reduces First Cardiovascular Events in High-Risk Patients Without Prior ASCVD: ACC 2026  patientcareonline.comAmgen’s Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate  simplywall.st